Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

News Daily News

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

Michael O'Riordan

February 09, 2024

News Daily News

Similar Outcomes in Men and Women After Transcatheter Tricuspid Interventions

Michael O'Riordan

April 05, 2023

News Daily News

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

Michael O'Riordan

September 13, 2022

News Daily News

Good Results For TAVI in Bicuspid Valves, but Questions Persist

Michael O'Riordan

March 08, 2022

News Daily News

Complete Anesthesia Handover in Cardiac Surgery Leads to Worse Outcomes

Michael O'Riordan

February 16, 2022

News Daily News PCR London Valves 2021

Cardiologist Tests Positive for Omicron COVID-19 After Trip to PCR London Valves

Michael O'Riordan

December 01, 2021

News Daily News

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Michael O'Riordan

August 06, 2018

News Daily News

Sapien 是经导管肺动脉瓣置换的“可行、持久”方案

Michael O'Riordan

December 27, 2015

News Daily News

Sapien a ‘Viable and Durable’ Option in Transcatheter Pulmonary Valve Replacement

Michael O'Riordan

December 27, 2015

News Daily News

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

Michael O'Riordan

December 27, 2015

Advertisement

CVD Still the Leading Cause of Death and Disease Globally

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

Similar Outcomes in Men and Women After Transcatheter Tricuspid Interventions

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

Good Results For TAVI in Bicuspid Valves, but Questions Persist

Complete Anesthesia Handover in Cardiac Surgery Leads to Worse Outcomes

Cardiologist Tests Positive for Omicron COVID-19 After Trip to PCR London Valves

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Sapien 是经导管肺动脉瓣置换的“可行、持久”方案

Sapien a ‘Viable and Durable’ Option in Transcatheter Pulmonary Valve Replacement

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content